Fig. 3

Survival curve analysis for sub-groups of CRC patients when defined by combined IL-36α and IL-36β production level (a) or IL-36α and IL-36γ (b), or IL-36β and IL-36γ (c), using the Kaplan-Meier method and the log-rank test
Survival curve analysis for sub-groups of CRC patients when defined by combined IL-36α and IL-36β production level (a) or IL-36α and IL-36γ (b), or IL-36β and IL-36γ (c), using the Kaplan-Meier method and the log-rank test